Artificial Intelligence (AI) has emerged as a transformative technology, revolutionizing various industries. The AI sector offers exciting investment opportunities, including AI penny stocks. Despite their relatively low share prices, these stocks represent companies with immense growth potential.

AI technology has witnessed exponential growth in recent years, driven by advancements in machine learning, natural language processing, computer vision, and robotics. AI technology has the potential to automate tasks, improve efficiency, and provide intelligent insights across multiple sectors.

This article explores four stocks harnessing AI technology, highlighting its growth prospects and the diverse areas in which AI will be utilized.

EPAZZ INC. (OTC: EPAZ)

Epazz, Inc. (EPAZ) is a compelling company that warrants attention in the investment landscape. Positioned as a mission-critical provider, EPAZ offers a range of solutions, including drone technology, blockchain mobile apps, and cloud-based business software.

One particular area of interest within EPAZ is its spinoff venture, ZenaDrone, which has garnered notable investor interest. ZenaDrone Inc. has quickly established itself as a rising star in the drone sector, largely due to its innovative integration of artificial intelligence (AI) technology.

Initially focused on disrupting the hemp farming sector, ZenaDrone has since expanded its horizons to deliver the ZenaDrone 1000, a comprehensive and intelligent unmanned aerial vehicle (UAV) solution. This autonomous drone is purpose-built for industrial applications across sectors such as military, construction, agriculture, surveillance, and search and rescue.

The ZenaDrone 1000 has received widespread acclaim for its advanced software and hardware, making it a versatile solution that caters to various customizable applications. Notably, it has gained recognition across industries including the military, agriculture, oil and gas, wildfire management, and civil engineering. Equipped with advanced features like machine learning systems, multispectral sensors, and AI technology, the drone effectively captures valuable data through its cameras, enabling the creation of interactive 3D environments.

EPAZ has already lined up compelling demonstrations for prominent clients, including the U.S. military, NATO partners, Irish farmers, the German police force, the German rail, and Native American tribes. To meet the rising demand, ZenaDrone is expanding its manufacturing facility to produce over 30 drones per month. The company also plans to scale its workforce to accommodate the increased production.

Shaun Passley, Ph.D., the CEO of Epazz, has expressed optimism regarding the progress of ZenaDrone 1000's sales pipeline, indicating a positive trajectory towards revenue generation.

Looking ahead, ZenaDrone Inc. aims to further augment the AI capabilities of the ZenaDrone 1000. This includes advancing autonomous navigation in unmapped terrain, implementing deep learning algorithms for diverse actions, and introducing dual-use functionality suitable for both commercial and military drone applications. As ZenaDrone continues to leverage the power of AI, investors are closely monitoring its potential to drive innovation and reshape the drone industry through state-of-the-art AI-driven solutions.

LANTERN PHARMA INC. (NASDAQ: LTRN)

LTRN, a clinical-stage biotechnology company, is positioning itself as a key player in the battle against cancer by leveraging the power of artificial intelligence (AI) technologies. With a strong focus on machine learning and genomic data, Lantern Pharma aims to streamline the drug development process and drive innovative cancer treatments.

The company's novel platform harnesses AI and machine learning algorithms to analyze an astounding 25 billion data points. This comprehensive approach enables Lantern Pharma to identify potential compounds that could significantly benefit cancer patients. By leveraging advanced genomics, Lantern Pharma breathes new life into previously failed drugs by effectively detecting overlooked genomic signatures.

By leveraging AI, LTRN is revolutionizing the traditional drug discovery model, reducing timelines and costs associated with the development process. While the conventional early-stage drug discovery model typically takes 3 to 5 years, Lantern Pharma's streamlined approach cuts it down to just 2 years. Similarly, the later stages of drug development can be expedited from 6 to 12 years under the traditional model to a more efficient three to five years with Lantern Pharma's AI-driven methodology.

Lantern Pharma's innovative methods mean substantial cost savings. Compared to traditional drug development models, Lantern Pharma estimates a reduction of over 70% in both early- and later-stage drug development costs.

With a unique ability to identify promising compounds and expedite the drug development timeline, Lantern Pharma could be poised to make a notable impact in the fight against cancer.

ONECONNECTION FINANCIAL TECHNOLOGY (NYSE: OCFT)

Shenzhen-based fintech solutions provider OCFT is making waves in the financial industry with its AI-powered platform. By harnessing the power of automation and machine learning, OneConnect empowers financial institutions to make more informed decisions while streamlining loan origination, underwriting, and risk management processes.

OneConnect's cloud-based platform and online information services have revolutionized the lending sphere, bringing efficiency, enhanced service quality, and reduced costs and risks to its clients. The company's commitment to digital transformation and market-leading technology has positioned it as a trailblazer in the fintech space.

In their recently announced unaudited financial results for the first quarter of 2023, OneConnect demonstrated impressive growth and improved financial indicators. Despite a slight decrease in revenue, the company showcased significant advancements:

Gross margin: OneConnect witnessed a notable increase in gross margin by 2.8 percentage points year-over-year, reaching 37.1%. The non-IFRS gross margin also saw an improvement, rising to 40.4%.

Operating loss: The company successfully narrowed its operating loss by 67.8%, amounting to RMB114 million. Operating loss margin also saw a significant reduction, from 34.8% to 12.4% compared to the same period of the prior year.

Net loss: OneConnect achieved a remarkable 65.7% reduction in net loss attributable to shareholders, amounting to RMB109 million. Additionally, the net loss ratio to shareholders improved by 19.4 percentage points, reaching -11.8%.

Earnings per ADS: Net loss per ADS, on a basic and diluted basis, showed a substantial improvement from RMB-8.58 to RMB-3.00 for the same period of the prior year.

OneConnect's financial performance underscores its ability to leverage AI technology effectively, delivering value to both its shareholders and the financial institutions it serves. By continuously refining its AI-driven software and expanding its services across the financial services ecosystem, the company solidifies its position as a leader in technology-enabled business solutions.

The innovative approach of OneConnect Financial Technology serves as a testament to the potential of AI to revolutionize the financial services industry. As the company continues to demonstrate remarkable growth and improved financial indicators, investors and stakeholders can expect further advancements in the realm of AI-powered fintech solutions.

OBLONG (NASDAQ: OBLG)

OBLG is a provider of innovative and patented technologies focused on the way people work, create, and communicate. At the forefront of its product lineup is the Mezzanine platform, a workplace meeting technology solution designed to optimize audience engagement and situational awareness through simultaneous content sharing.

With its flagship product, Mezzanine, Oblong is redefining virtual meetings by enabling real-time collaboration and immersive group chat experiences on an enterprise scale. While not deeply entrenched in artificial intelligence, Oblong's product offerings hold immense potential for leveraging AI capabilities to enhance their services and drive further growth.

The global video conferencing market is poised for explosive growth, projected to reach a staggering $17.05 billion by 2030, representing an increase of $9.3 billion from 2023. As organizations increasingly embrace remote work and virtual collaboration, the demand for innovative solutions like Oblong's Mezzanine is expected to soar.

Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) is owned by RazorPitch Inc. and has been retained by Epazz Inc. to assist in the production and distribution of content. 'CGR' is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport/RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR/RazorPitch is not a fiduciary by virtue of any persons use of or access to this content.

CapitalGainsReport

Mark McKelvie

Editor

markrmckelvie@gmail.com

.

(C) 2023 M2 COMMUNICATIONS, source M2 PressWIRE